Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
OtherCLINICAL INVESTIGATIONS

Comparison of Cardiac Sympathetic Nervous Function with Left Ventricular Function and Perfusion in Cardiomyopathies by 123I-MIBG SPECT and 99mTc-Tetrofosmin Electrocardiographically Gated SPECT

Chunlei Zhao, Noriyuki Shuke, Wakako Yamamoto, Atsutaka Okizaki, Junichi Sato, Yukio Ishikawa, Takahumi Ohta, Naoyuki Hasebe, Kenjiro Kikuchi and Tamio Aburano
Journal of Nuclear Medicine July 2001, 42 (7) 1017-1024;
Chunlei Zhao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noriyuki Shuke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wakako Yamamoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Atsutaka Okizaki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junichi Sato
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yukio Ishikawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takahumi Ohta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naoyuki Hasebe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenjiro Kikuchi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tamio Aburano
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

The objective of this study was to clarify the relationship between cardiac sympathetic nervous function (CSNF) and left ventricular (LV) function and perfusion in hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). Methods: Thirty-eight cases (32 males, 6 females; mean age, 56 ± 15 y), consisting of 5 healthy control subjects, 15 patients with DCM, and 18 patients with HCM, were studied with 123I-metaiodobenzylguanidine (MIBG) and 99mTc-tetrofosmin SPECT. CSNF was evaluated from cardiac uptake and washout of MIBG, whereas LV perfusion and function were evaluated from tetrofosmin uptake and wall thickening on electrocardiographically gated SPECT. As quantitative parameters of global cardiac MIBG uptake and washout, the heart-to-mediastinum ratio (H/M) and percentage washout were calculated from early and delayed planar images. As quantitative regional parameters, the regional uptake and percentage washout of MIBG were calculated from SPECT images dividing the left ventricle into 12 segments. In the tetrofosmin study, the H/M and LV ejection fraction were calculated as the parameters of global LV perfusion and function. As quantitative regional parameters, the regional uptake and wall thickening were also calculated for the 12 myocardial segments using the quantitative gated SPECT software. Multiple linear regression analysis was performed to investigate the correlations between the parameters from the 2 studies. Results: In DCM and HCM, multiple linear regression analysis of the regional parameters showed significant correlations between LV function and CSNF (P < 0.0001) and between LV perfusion and CSNF (P < 0.0001). According to the partial correlation coefficients, washout and early uptake of MIBG were the most significant factors for predicting LV function and LV perfusion, respectively. Conclusion: In cardiomyopathies, CSNF was closely related to LV function. The quantitative parameters of MIBG washout could reflect cardiac functional impairment. Early MIBG uptake might be determined by myocardial perfusion in cardiomyopathies.

  • hypertrophic cardiomyopathy
  • dilated cardiomyopathy
  • 123I-metaiodobenzylguanidine
  • 99mTc-tetrofosmin
  • gated myocardial SPECT

Metaiodobenzylguanidine (MIBG) has similar structure and the same uptake and storage mechanisms as norepinephrine (NE) (1). MIBG is stored in presynaptic vesicles and is secreted in response to acetylcholine released from the preganglionic neuron (2,3). 123I-MIBG was developed for evaluating cardiac sympathetic nervous function (CSNF), and the usefulness of 123I-MIBG imaging has been generally accepted for many diseases, such as heart failure, diabetes, Parkinson’s disease, and cardiomyopathy (4–9). Decreased cardiac MIBG uptake was thought to reflect impaired adrenergic nervous function or denervation in these diseases. The heart-to-mediastinum ratio (H/M) at 3–4 h after injection appears to be a good quantitative index of neuronal MIBG uptake in the clinical situation (1), although this index is not sensitive enough to detect the slight reduction of MIBG accumulation (10). As for the relationship between MIBG uptake and left ventricular (LV) function, decreased MIBG uptake on delayed images was closely related to LV dysfunction in patients with heart failure (11,12). In other studies, sympathetic denervation was found to exist with normal LV function at rest (13,14). Cardiac MIBG washout rate is another index that could represent sympathetic nervous activity related to NE storage ability (15). However, the clinical significance of this index has not been fully clarified. Patients with cardiomyopathy had rapid washout of MIBG (8,16), whereas the results were controversial in the patients with diabetes (17,18). Considering these reported results, the relationship between CSNF and LV function may differ depending on the type of disease and may not be explained by a common theory. In this study, we investigated the relationship between CSNF evaluated from uptake and washout of MIBG and LV function and myocardial perfusion in the patients with dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM) to clarify the clinical significance of MIBG imaging in these diseases.

Electrocardiographically (ECG) gated SPECT with 99mTc-tetrofosmin and the quantitative gated SPECT software were applied to analyze LV perfusion and function simultaneously. This approach could make it easy to compare regional MIBG uptake or washout with LV perfusion or function on a myocardial segment-by-segment basis.

MATERIALS AND METHODS

Thirty-eight cases (32 males, 6 females; mean age, 56 ± 15 y; age range, 15–77 y), consisting of 5 healthy control subjects (normal controls [NCs]), 15 patients with DCM, and 18 patients with HCM, were studied. Seven patients with DCM were clinically diagnosed as having chronic heart failure, and 4 patients with HCM were in the dilated phase. 123I-MIBG SPECT and 99mTc-tetrofosmin gated SPECT were performed on these subjects within 2 wk without any medical intervention. 123I-MIBG (MyoMIBG-I-123; 111 MBq/0.03–0.10 mg) and the 99mTc generator system (Ultra-TechneKow) were purchased from Daiichi Radioisotope Laboratory (Tokyo, Japan). 99mTc-tetrofosmin was prepared using a kit vial of tetrofosmin (Myoview; Nihon-Mediphysics, Tokyo, Japan) and freshly eluted 99mTc-pertechnetate.

Imaging Protocol

We performed early and delayed 123I-MIBG imaging using a single-head, rotating gamma camera equipped with a low-energy, general-purpose collimator (RC-135E; Hitachimedico, Tokyo, Japan). Early imaging began 15 min after an intravenous injection of 111 MBq 123I-MIBG. Before SPECT acquisition, an anterior chest image was acquired for 300 s in a 128 × 128 matrix. Immediately after planar imaging, 32 images were obtained in a 64 × 64 matrix for 40 s, with a 180° rotation and an energy window of 10% centered at 160 keV. Delayed planar imaging and SPECT imaging were performed 4 h after the injection under the same acquisition conditions as used in the early imaging.

For ECG gated 99mTc-tetrofosmin SPECT, we used a triple-head, rotating gamma camera equipped with a low-energy, high-resolution collimator (GCA-9300A/DI; Toshiba Medical, Tokyo, Japan). Sixty images were obtained using the R wave on electrocardiography as a trigger of acquisition in a 64 × 64 matrix for 30 s, over 360°, with an energy window of 10% centered at 140 keV at 2 h after an intravenous injection of 740 MBq 99mTc-tetrofosmin. Each image was partitioned into 8 or 16 frames per cardiac cycle.

Reconstruction was performed without attenuation and scatter correction by a filtered backprojection algorithm for 123I-MIBG and 99mTc-tetrofosmin studies. After preprocessing with a Butterworth filter (cutoff frequency, 0.44 cycle/cm; power factor, 8), transaxial images were reconstructed with a ramp filter. Long- and short-axial slices were then produced by axial reorientation.

Data Processing

On the anterior planar 123I-MIBG images, regions of interest (ROIs) were drawn over the whole heart and upper mediastinum. Using the counts in the ROIs, the H/M and global cardiac washout (GW) of MIBG were calculated as follows: Math Math where the H/M from early and delayed images is H/Me and H/Md, respectively. Decay correction was done for calculating GW.

Regional uptake and washout of 123I-MIBG were analyzed using dedicated software after repositioning the center of early and delayed short-axial slices to the same position. In this analysis, the left ventricle was divided into 3 parts from the apex to the base, perpendicularly to the long axis of the heart. Each part was then divided into 6 segments on a short-axial plane: inferior septal, anterior septal, anterior, anterior lateral, inferior lateral, and inferior segments. Twelve segments from middle and apical parts were used (Fig. 1). After drawing circular ROIs on a short-axial plane for determining outer and inner edges of the myocardium, mean voxel counts of each segment were calculated. Using the mean voxel counts, the regional washout (RW) and uptake index (MUP) were calculated on a myocardial-segment basis as follows: Math Math where the MUP, the product of relative regional uptake and H/M, was introduced to compare absolute regional MIBG uptake. The MUP of early and delayed images is MUPe and MUPd, respectively. Decay correction was done for calculating RW.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Diagram of myocardial segments of left ventricle on short-axial plane. IS = inferior septal; AS = anterior septal; ANT = anterior; AL = anterior lateral; IL = inferior lateral; INF = inferior.

To calculate the H/M of 99mTc-tetrofosmin (H/M-tetrofosmin), ROIs of the heart and mediastinum were drawn on an anterior image from merged nongated SPECT images because planar imaging was not performed in the 99mTc-tetrofosmin study. Applying the quantitative gated SPECT software to the ECG gated SPECT images, LV ejection fraction (LVEF), wall thickening (TH), and relative regional end-systolic and end-diastolic uptake that was normalized by the highest voxel counts were computed and displayed in the bull’s eye maps. The same segments as shown in Figure 1 were used for the analysis. Regional end-systolic uptake was selected as the parameter of regional perfusion. To compare the absolute levels of regional 99mTc-tetrofosmin uptakes among individual segments, we introduced the uptake index (UPes), defined as the product of regional uptake at end-systole and H/M-tetrofosmin: Math

The parameters from both studies are summarized in Table 1. Examples of the images of 123I-MIBG and 99mTc-tetrofosmin studies for NC, DCM, and HCM are shown in Figure 2.

View this table:
  • View inline
  • View popup
TABLE 1

Global and Regional Parameters in Study

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

Examples of 99mTc-tetrofosmin and 131I-MIBG SPECT. Short-axial images of 55-y-old healthy man (A), 59-y-old man with DCM (B), and 15-y-old boy with HCM (C). In DCM and HCM, myocardial MIBG uptake was significantly decreased on delayed images.

The mean and SD of the TH value calculated from 60 myocardial segments of 5 NCs were used to classify all segments of the patients according to the degree of asynergy. Altogether, 396 segments were divided into 3 groups according to their TH values: normal (N; TH > mean minus SD), moderate asynergic (M; mean minus 2SD < TH ≤ mean minus SD), and severe asynergic (S; TH ≤ mean minus 2SD). The group means of other regional parameters were calculated and compared on the basis of this classification.

Statistical Analysis

One-way ANOVA was applied for comparing the parameters from 123I-MIBG and 99mTc-tetrofosmin studies. To determine if the factors were independently related to LV function or perfusion, the parameters from the MIBG study were examined by multiple linear regression analysis. Sample correlation coefficients and partial correlation coefficients were calculated. P < 0.05 was considered significant in all tests.

RESULTS

Global Parameters

The means of patients’ age and global parameters in NC, DCM, and HCM are listed in Table 2. No significant difference was found in age. The means of LVEF, H/Md, and GW were significantly different among the 3 categories, in decreasing order of NC, HCM, and DCM for LVEF and H/Md and in opposite order for GW. The H/M-tetrofosmin in HCM was significantly greater than that in DCM, but the H/M-tetrofosmin in NC showed no significant differences from those in HCM and DCM. The H/Me in NC and HCM were significantly greater than that in DCM, but no significant difference was found between NC and HCM. Within the DCM category, the LVEF of patients with heart failure showed a significantly lower value than that of patients without heart failure. Within the HCM category, the LVEF and H/Me of patients in nondilated phase were significantly greater than those of patients in dilated phase.

View this table:
  • View inline
  • View popup
TABLE 2

Patients’ Age and Global Parameters in NC, DCM, and HCM

Regional Parameters

Two patients (1 with DCM and 1 with HCM) were omitted from regional analyses in the MIBG study because of nonvisualization of their hearts.

Descriptive statistics of regional parameters in NC, DCM, and HCM are listed in Table 3. The means of TH, RW, and MUPd among the 3 categories were significantly different, in decreasing order of NC, HCM, and DCM for TH and MUPd and in opposite order for RW. The means of UPes and MUPe were also significantly different among the 3 categories, becoming smaller in the order of HCM, NC, and DCM. Within the DCM category, all parameters except UPes showed significant differences between the patients with heart failure and those without heart failure. Within the HCM category, all parameters except RW showed significant differences between the patients in dilated phase and those in nondilated phase. UPes and MUPe of the patients with HCM in dilated phase were significantly decreased compared with NC.

View this table:
  • View inline
  • View popup
TABLE 3

Regional Parameters in NC, DCM, and HCM

The normal TH value was 54.6% ± 17.7% (mean ± SD). All 396 segments of the patients were classified into N, M, and S groups according to the deviation of their TH values from the normal mean. The group means of RW, UPes, MUPe, and MUPd were significantly different among the 3 groups (P < 0.05), and their values were correlated with the degree of asynergy (Fig. 3).

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

Group means of regional parameters. n = number of myocardial segments; UPes = tetrofosmin uptake at end-systole; MUPe = early MIBG uptake; MUPd = delayed MIBG uptake.

Correlation Among Global Parameters

The values of multiple correlation coefficients between observed values of LVEF and the values predicted from the global MIBG parameters (H/Me, H/Md, and GW) were 0.513 (P = 0.321) in DCM and 0.425 (P = 0.410) in HCM. These values indicated no significant correlations between LVEF and the global MIBG parameters in DCM and HCM.

The values of multiple correlation coefficients between observed values of H/M-tetrofosmin and the values predicted from the global MIBG parameters were 0.570 (P = 0.212) in DCM and 0.774 (P = 0.0043) in HCM. Thus, the global MIBG parameters showed only a significant correlation with H/M-tetrofosmin in HCM. The partial correlation coefficients between H/Me, H/Md, GW, and H/M-tetrofosmin were 0.764 (P < 0.001), −0.612 (P < 0.05), and −0.365 (P > 0.1). These values indicated significant correlations of early and delayed MIBG uptake with LV perfusion in HCM.

Correlation Among Regional Parameters

The values of multiple correlation coefficients between observed values of TH and the values predicted from the regional MIBG parameters (MUPe, MUPd, and RW) were 0.535 (P < 0.0001) in DCM and 0.407 (P < 0.0001) in HCM. These values indicated significant correlations between the regional LV function and the regional MIBG parameters in DCM and HCM. In DCM, the values of partial correlation coefficients between MUPe, MUPd, RW, and TH were 0.280 (P < 0.001), −0.123 (P > 0.1), and −0.304 (P < 0.0001). In HCM, these values were −0.012 (P > 0.1), 0.104 (P > 0.1), and −0.154 (P < 0.05).

The values of multiple correlation coefficients between observed values of UPes and the values predicted from the regional MIBG parameters (MUPe, MUPd, and RW) were 0.560 (P < 0.0001) in DCM and 0.552 (P < 0.0001) in HCM. These values indicated significant correlations between the regional LV perfusion and the regional MIBG parameters in DCM and HCM. In DCM, the values of partial correlation coefficients between MUPe, MUPd, RW, and UPes were 0.356 (P < 0.00001), −0.176 (P < 0.05), and −0.328 (P < 0.0001). In HCM, these values were 0.307 (P < 0.00001), −0.097 (P > 0.1), and 0.144 (P < 0.05). In DCM and HCM, early MIBG uptake showed the best correlation with LV perfusion.

Table 4 shows sample correlation coefficients between the parameters in DCM and HCM. TH and UPes showed a significant correlation with all regional MIBG parameters. The correlation coefficients between TH and RW were −0.412 (P < 0.001) in DCM and −0.350 (P < 0.001) in HCM (Fig. 4). The correlation coefficients between UPes and MUPe were 0.419 (P < 0.001) in DCM and 0.461 (P < 0.001) in HCM (Fig. 5).

View this table:
  • View inline
  • View popup
TABLE 4

Correlation Coefficients (r values) Between Regional Parameters

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

Correlation between regional MIBG washout and wall thickening in DCM and HCM. n = number of myocardial segments.

FIGURE 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 5.

Correlation between regional early MIBG uptakes and perfusion in DCM and HCM. n = number of myocardial segments.

DISCUSSION

Cardiomyopathies are myocardial diseases that are often presented with severe cardiac dysfunction and can be classified into dilated, restrictive, and hypertrophic types on the basis of etiology, pathophysiology, and clinical manifestation (19). Cardiac MIBG uptake often decreases in patients with cardiomyopathies; this decrease could reflect abnormal CSNF associated with cardiomyopathy (8,9,16,20,21). However, little is known about the relationship between cardiac sympathetic disorders and the pathophysiology of cardiomyopathies, especially LV function and perfusion. In this context, we performed our study and found that CSNF evaluated from cardiac MIBG imaging was closely related to LV function in patients with DCM and HCM.

In this study, the HCMs of the nondilated phase were better compared with NCs in terms of myocardial tetrofosmin uptake and early cardiac MIBG uptake but, on the contrary, were worse in LV function, delayed uptake, and washout of MIBG. These results indicated that LV function and CSNF could be disordered, even though myocardial perfusion was reserved in the HCMs of the nondilated phase. However, among the 3 categories of NC, HCM, and DCM, DCMs had the lowest LV function and perfusion associated with the lowest uptake and the fastest washout of MIBG. These findings were in good agreement with the pathophysiologic characteristics of DCM (19).

Previous studies suggested that cardiac MIBG uptake was correlated with the parameters of LV function, such as LVEF, cardiac index, end-diastolic pressure, and regional wall motion, in heart failure (11) and myocardial infarction (1). However, in cardiomyopathy, the relationship between cardiac MIBG uptake and LV function has not been fully clarified. Cardiac MIBG washout, which is a commonly used parameter in MIBG studies, showed variability in various diseases (8,16–18). Yamakado et al. (20) reported a significant correlation between cardiac MIBG washout and LV function in DCM. In agreement with this finding, our results showed that regional MIBG washout was the most significant independent factor related to regional function in DCM and HCM. These results suggested that MIBG washout was closely correlated with LV function and could be a useful parameter reflecting LV function in patients with cardiomyopathies. On the basis of the results showing that abnormalities of CSNF were related to impaired LV function in DCM and HCM, the association between CSNF and LV function might be independent of the type of cardiomyopathies.

Earlier studies on patients with DCM and HCM indicated that delayed cardiac MIBG uptake was independent of myocardial blood flow and that MIBG distributed more heterogeneously compared with blood flow tracers in delayed phase (8,20,21). However, early cardiac distribution of MIBG was similar to that of blood flow tracers (20,21). In keeping with these findings, our results showed that regional early MIBG uptake was the most significant factor for predicting LV function in DCM and HCM. Considering these findings, early MIBG uptake might be largely dependent on the blood flow in DCM and HCM. Simple linear regression analysis showed that regional MIBG washout was inversely correlated with regional perfusion in DCM, whereas it was positively correlated with regional perfusion in HCM. These findings imply that the kinetics of MIBG might be different in these 2 types of cardiomyopathies.

Histologic abnormalities of the myocardium in cardiomyopathies (such as degeneration, fibrosis, and so forth) have been reported to be associated with decreased cardiac MIBG uptake (7,9). These histologic abnormalities in cardiomyopathies might impair sympathetic nervous function or the ability of NE storage, resulting in the reduced uptake and rapid washout of MIBG on delayed images. On the other hand, other studies have indicated that decreased MIBG uptake was related to sympathetic denervation or the impairment of neuronal uptake function in the patients with heart failure and diabetes (12,22). However, it is unclear in cardiomyopathies whether sympathetic denervation or the impairment of neuronal uptake function causes the decrease of MIBG uptake. We found that, although delayed MIBG uptake decreased in DCM and HCM, early MIBG uptake in the HCMs of the nondilated phase was even better than that in NCs. These findings indicate that the early MIBG uptake mechanism was not damaged in the early phase of HCM. Dae et al. (23) found that specific neuronal uptake is dominant in the mechanism of human myocardial NE uptake. Therefore, considering this finding and our results indicating that early MIBG uptake in the HCMs of the nondilated phase was not reduced and early MIBG uptake in HCM was correlated significantly with blood flow, the impairment of neuronal uptake function might not be dominant in HCM. On the other hand, in DCM, early MIBG uptake was worse than that in NCs. However, it is doubtful whether this low early MIBG uptake in DCM is caused by the low perfusion other than the impaired neuronal uptake function, even though our results showed that the low early MIBG uptake was closely associated with the low perfusion in DCM. The mechanisms of the uptake and rapid washout of MIBG in cardiomyopathies remain to be clarified.

The H/M used for normalizing tracer uptake in the study was measured from planar images because it was a simple and reproducible way to evaluate the tracer uptake (12). However, planar imaging had its own limitations because the heart counts included the counts of overlying lung (12,22). Thus, in the patient whose cardiac uptake of the tracer was decreased significantly, the H/M might be overestimated. We failed to determine the significant global MIBG parameters for predicting LV perfusion in DCM and for predicting LV function in DCM and HCM. This failure might be associated with the small sample; on the other hand, it could be explained by the limitations of the global parameters. A more accurate index should be sought to diminish this error.

Because data from the MIBG and tetrofosmin studies were acquired separately with different machines, the exact matching of the corresponding slices was nearly impossible. However, because the counts in neighboring slices from the same part were not too different (as found in this study), the errors caused by the slice selection might be limited to an acceptable range. We excluded the basal part of the myocardium from the regional analysis because it was relatively difficult to determine the border of this part and the slice selection in this part tended to cause more errors in the quantitative analyses.

The relationship between CSNF and LV function in DCM and HCM was determined in this study. These results suggested that MIBG could be helpful in obtaining pathophysiologic information on the patients with cardiomyopathies. However, it should be noted that the relationship between CSNF and LV function might be more complicated in other diseases. For example, normal cardiac function could coexist with sympathetic denervation in transplanted hearts (24). The relationship between MIBG imaging and LV function may vary in different diseases. More studies must be done to further understand the significance of MIBG imaging in different cardiovascular diseases.

CONCLUSION

In patients with DCM and HCM, CSNF was closely related to LV function, the quantitative parameters of MIBG washout that could reflect cardiac functional impairment in cardiomyopathies. Early cardiac MIBG uptake might be largely dependent on the myocardial perfusion in cardiomyopathies.

Footnotes

  • Received Nov. 14, 2000; revision accepted Mar. 5, 2001.

    For correspondence or reprints contact: Chunlei Zhao, MD, Department of Radiology, Asahikawa Medical College, 2-1 Midorigaoka-Higashi, Asahikawa, Japan, 078-8510.

REFERENCES

  1. ↵
    Valette H, Syrota A. Nuclear techniques in the assessment of myocardial innervation. In: Murry IPC, Ell PJ, eds. Nuclear Medicine in Clinical Diagnosis and Treatment Edinburgh, U.K.: Churchill Livingstone; 1998:1525–1529.
  2. ↵
    Wieland DM, Brown LE, Tobes MC, et al. Imaging the primate adrenal medullae with [123I] and [131I] meta-iodobenzylguanidine. J Nucl Med 1981;22:358–364.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Jaques S Jr, Toes MC. Comparison of the secretory mechanisms of meta-iodobenzylguanidine (MIBG) and norepinephrine (NE) from cultured bovine adrenomedullary cells. J Nucl Med 1985;26:17–26.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Atsumi H, Takeishi Y, Fujiwara S, Tomoike H. Cardiac sympathetic nervous disintegrity is related to exercise intolerance in patients with chronic heart failure. Nucl Med Commun 1998;19:451–456.
    OpenUrlPubMed
  5. Murata K, Sumida Y, Murashima S, et al. A novel method for the assessment of autonomic neuropathy in type 2 diabetic patients: a comparative evaluation of 123I-MIBG myocardial scintigraphy and power spectral analysis of heart rate variability. Diabet Med 1996;13:266–272.
    OpenUrlCrossRefPubMed
  6. Iwasa K, Nakajima K, Yoshikawa H, Tada A, Taki J, Takamori M. Decreased myocardial 123I-MIBG uptake in Parkinson’s disease. Acta Neurol Scand 1998;97:303–306.
    OpenUrlPubMed
  7. ↵
    Ueda T, Kusachi S, Yamaji H, Morishita N, Mima T, Imai M. Recovery of iodine-123 metaiodobenzylguanidine uptake associated with left ventricular functional recovery in a patient with dilated cardiomyopathy: endomyocardial histological findings before and after the improvement of uptake. Jpn Heart J 1997;38:145–150.
    OpenUrlPubMed
  8. ↵
    Yoshimura N, Kimura M, Ozaki T, Takahashi N, Sakai K. Two patients with hypertrophic cardiomyopathy showing regionally increased washout of 123I-MIBG from the thick myocardium [in Japanese]. Kaku Igaku 1998;35:315–320.
    OpenUrlPubMed
  9. ↵
    Murata K, Kusachi S, Murakami T, et al. Relation of iodine-123 metaiodobenzylguanidine myocardial scintigraphy to endomyocardial biopsy findings in patients with dilated cardiomyopathy. Clin Cardiol 1997;20:61–66.
    OpenUrlPubMed
  10. ↵
    Hattori N, Tamaki N, Hayashi T, et al. Regional abnormality of iodine-123-MIBG in diabetic hearts. J Nucl Med 1996;37:1985–1990.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Schofer J, Spielmann R, Schubert A, Weber K, Schluter M. Iodine-123 metaiodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1988;12:1252–1258.
    OpenUrlPubMed
  12. ↵
    Merlet P, Valette H, Dubois-Rande JL, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992;33:471–477.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Langer A, Freeman MR, Josse RG, Armstrong PW. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia. J Am Coll Cardiol 1995;25:610–618.
    OpenUrlCrossRefPubMed
  14. ↵
    Wakasugi S, Fishchman AJ, Babich JW, et al. Metaiodobenzylguanidine: evaluation of its potential as a tracer for monitoring doxorubicin cardiomyopathy. J Nucl Med 1993;34:1283–1286.
    OpenUrlPubMed
  15. ↵
    Nagamachi S, Jinnouchi S, Kurose T, et al. 123I-MIBG myocardial scintigraphy in diabetic patients: relationship with 201Tl uptake and cardiac autonomic function. Ann Nucl Med 1998;12:323–331.
    OpenUrlPubMed
  16. ↵
    Henderson EB, Kahn JK, Corbett JR, et al. Abnormal I-123 myocardial metaiodobenzylguanidine washout and distribution may reflect myocardial adrenergic derangement in patients with congestive heart cardiomyopathy. Circulation 1988;78:1192–1199.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Nagamachi S, Jinnouchi S, Nakahara H, et al. 123I-MIBG myocardial scintigraphy in diabetic patients: relationship to autonomic neuropathy. Nucl Med Commun 1996;17:621–632.
    OpenUrlPubMed
  18. ↵
    Mantysaari M, Kuikka J, Mustonen J, et al. Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I]metaiodobenzylguanidine. Diabetes 1992;41:1069–1075.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Stevenson LW. Diseases of the myocardium. In: Bennett JC, Plum F, eds. Cecil Textbook of Medicine Philadelphia, PA: WB Saunders; 1996:327–336.
  20. ↵
    Yamakado K, Takeda K, Kitano T, et al. Serial change of iodine-123 metaiodobenzylguanidine (MIBG) myocardial concentration in patients with dilated cardiomyopathy. Eur J Nucl Med 1992;19:265–270.
    OpenUrlPubMed
  21. ↵
    Nakajima K, Bunko H, Taki J, Shimizu M, Muramori A, Hisada K. Quantitative analysis of 123I-meta-iodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy. Am Heart J 1990;119:1329–1337.
    OpenUrlCrossRefPubMed
  22. ↵
    Kim SJ, Lee JD, Ryu YH, et al. Evaluation of cardiac sympathetic neuronal integrity in diabetic patients using iodine-123 metaiodobenzylguanidine. Eur J Nucl Med 1996;23:401–406.
    OpenUrlCrossRefPubMed
  23. ↵
    Dae MW, De Marco T, Botvinick EH, et al. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts: implications for clinical studies. J Nucl Med 1992;33:1444–1450.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Bengel F, Schiepel P, Ueberfuhr P, Nekolla S, Reichart B, Schwaiger M. Effect of sympathetic reinnervation on efficiency of the transplanted heart [abstract]. J Nucl Med 2000;41.(suppl):50P.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 42, Issue 7
July 1, 2001
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of Cardiac Sympathetic Nervous Function with Left Ventricular Function and Perfusion in Cardiomyopathies by 123I-MIBG SPECT and 99mTc-Tetrofosmin Electrocardiographically Gated SPECT
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Comparison of Cardiac Sympathetic Nervous Function with Left Ventricular Function and Perfusion in Cardiomyopathies by 123I-MIBG SPECT and 99mTc-Tetrofosmin Electrocardiographically Gated SPECT
Chunlei Zhao, Noriyuki Shuke, Wakako Yamamoto, Atsutaka Okizaki, Junichi Sato, Yukio Ishikawa, Takahumi Ohta, Naoyuki Hasebe, Kenjiro Kikuchi, Tamio Aburano
Journal of Nuclear Medicine Jul 2001, 42 (7) 1017-1024;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comparison of Cardiac Sympathetic Nervous Function with Left Ventricular Function and Perfusion in Cardiomyopathies by 123I-MIBG SPECT and 99mTc-Tetrofosmin Electrocardiographically Gated SPECT
Chunlei Zhao, Noriyuki Shuke, Wakako Yamamoto, Atsutaka Okizaki, Junichi Sato, Yukio Ishikawa, Takahumi Ohta, Naoyuki Hasebe, Kenjiro Kikuchi, Tamio Aburano
Journal of Nuclear Medicine Jul 2001, 42 (7) 1017-1024;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Risk Stratification in Heart Failure Using 123I-MIBG
  • Cardiac 123I-MIBG Reflects Left Ventricular Functional Reserve in Patients with Nonobstructive Hypertrophic Cardiomyopathy
  • Cardiac Autonomic Neuropathy in the Diabetic Patient: Does 123I-MIBG Imaging Have a Role to Play in Early Diagnosis?
  • Changes in Cardiac Sympathetic Nerve Innervation and Activity in Pathophysiologic Transition from Typical to End-Stage Hypertrophic Cardiomyopathy
  • Cardiac Adrenergic Activity Is Associated with Left Ventricular Hypertrophy in Genetically Homogeneous Subjects with Hypertrophic Cardiomyopathy
  • Google Scholar

More in this TOC Section

  • Diagnostic Performance of 124I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
  • Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer 18F-FDG PET Radiomics
  • Utility of Equilibrium Radionuclide Angiogram–Derived Measures of Dyssynchrony to Predict Outcomes in Heart Failure Patients Undergoing Cardiac Resynchronization Therapy
Show more CLINICAL INVESTIGATIONS

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire